06 Nov A genome-wide CRISPR/Cas9 loss-of-function screen to identify mechanisms of chemo- and radiotherapy resistance in head and neck squamous cell carcinomas
Posted at 16:36h
in DRUG TOLERANCE
ID: 03328
Authors: Pozo Agundo, Esperanza (1,2,3); Álvarez González, Miguel (1,2,3); Hermida Prado, Francisco (1,2,3); Bestilleiro Márquez, Judit (1,2); Rivera García, Israel (1,2); Villacé Gallego, Alfonso (4); Sánchez Collantes, Natilia (5); Varela, Ignacio (5); Rodrigo Tapia, Juan P. (1,2,3,6); García Pedrero, Juana M. (1,2,3); Álvarez Frenández, Mónica (1,2)
Topic: DRUG TOLERANCE
Read